ESTABLISHED 2024 A CIVIC RECORD OF ACTIONS TAKEN AGAINST THE AMERICAN PEOPLE — AND HOW WE RESTORE THEM June 2, 2026
A nonpartisan civic restoration project

UndoTrump.com

★   ★   ★

Tracking every rollback, reversal, and overreach — and the path back to the America we know.

1,104
Actions Tracked
861
Still Active
31
In the Courts
34
Restored
498
Days Tracking

The Record

1,104 Actions  ·  Page 57 of 111
Active

Delegation of Functions Under 31 U.S.C. 5302 Regarding Reserve Requirements

On March 20, 2020, President Trump signed a memorandum delegating functions under 31 U.S.C. 5302 to the Secretary of the Treasury. The memorandum authorized the Treasury Secretary to exercise authority related to reserve requirements and financial regulations. The direct impact on Americans included potential changes to Treasury Department enforcement and regulatory implementation procedures, though the specific operational changes were limited in scope.

Expired

Executive Order 13909: Health and Medical Resources COVID-19 Response

Executive Order 13909 was signed on March 18, 2020, directing the prioritization and allocation of health and medical resources to respond to COVID-19 spread. The order invoked the Defense Production Act to enable the federal government to require private manufacturers to produce medical supplies and equipment needed for pandemic response. The order authorized federal officials to requisition ventilators, personal protective equipment, and other medical resources from private manufacturers and direct their distribution to areas with greatest need.

Expired

Proclamation suspending entry of certain persons amid coronavirus pandemic

On March 14, 2020, President Trump signed Proclamation 10597 suspending entry of certain immigrants and nonimmigrants deemed to pose a risk of transmitting COVID-19. The proclamation suspended issuance of immigrant visas and certain nonimmigrant visas for persons outside the United States. The order affected visa processing at U.S. consulates and entry at ports of entry, resulting in delays and rejections of visa applications and entry requests for affected categories.

Expired

Expanded State-Approved Diagnostic Tests During COVID-19

On March 13, 2020, the Trump administration signed Memorandum 2020-05793 authorizing states to approve diagnostic tests for COVID-19 without prior federal clearance. The memorandum allowed state health departments to validate and deploy tests more rapidly than the standard FDA approval process. This expanded the number of available COVID-19 tests Americans could access during the early pandemic period.

Active

Declaration of National Emergency for COVID-19 Outbreak

President Trump signed Proclamation 2020-5794 on March 13, 2020, declaring a national emergency concerning the novel coronavirus disease (COVID-19) outbreak. The proclamation invoked the National Emergencies Act and the Stafford Act, enabling the federal government to mobilize resources, waive certain regulations, and authorize emergency funding for pandemic response. The declaration activated emergency powers that allowed FEMA to coordinate disaster relief, permitted the Secretary of Health and Human Services to waive Medicare requirements, and authorized the use of the Defense Production Act to manufacture medical supplies.

Active

Continuation of National Emergency Declaration With Respect to Iran

On March 12, 2020, the Trump administration issued a notice continuing the national emergency with respect to Iran, originally declared in 1995 and renewed annually. The continuation extended the emergency declaration's legal authority, maintaining sanctions and restrictions on Iran-related transactions and activities. This action kept in place existing economic sanctions, travel restrictions, and asset freezes on Iran and Iranian entities affecting U.S. foreign policy and trade.

Expired

Proclamation suspending entry of certain persons due to COVID-19 transmission risk

On March 11, 2020, President Trump signed Proclamation 10578 suspending the entry of foreign nationals who had been physically present in designated countries within 14 days prior to entry into the United States, citing COVID-19 transmission risk. The proclamation applied restrictions to travelers from Iran, Italy, South Korea, and certain regions of China. The order affected travel to the United States for foreign nationals from these areas, while U.S. citizens and permanent residents were generally permitted entry with health screening.

Expired

Memorandum authorizing general use respirators during COVID-19

On March 11, 2020, President Trump signed Memorandum 2020-05580 directing the Food and Drug Administration to allow manufacturers to produce general use respirators (non-medical masks and coverings) without prior approval. The memorandum removed regulatory barriers to expand respirator availability during the COVID-19 pandemic. This enabled broader civilian access to respiratory protection equipment during the early pandemic response.

Active

Presidential Order on StayNTouch Acquisition by Beijing Shiji Information Technology

On March 6, 2020, the Trump administration issued Presidential Order 2020-05011 regarding the proposed acquisition of StayNTouch, Inc., a U.S. hospitality software company, by Beijing Shiji Information Technology Co., Ltd., a Chinese company. The order blocked or restricted the transaction based on national security concerns. The direct effect was to prevent the Chinese company from acquiring control of the American software platform used by hotels and hospitality businesses.

Active

Continuation of National Emergency Declaration Regarding Venezuela

On March 5, 2020, the Trump administration continued the national emergency with respect to Venezuela through Notice 2020-04822. The continuation extended the emergency declaration originally issued in 2019, maintaining executive authorities to impose sanctions and restrictions related to Venezuelan officials and entities. The declaration remained in effect, allowing the administration to enforce economic sanctions against Venezuela without requiring Congressional approval.